Moret, C, Acosta-Isaac, R, Mojal, S, Corrochano, M, Jimenez, B, Plaza, M, Souto, JC. Clinical outcomes in patients with atrial fibrillation treated with DOACs in a specialized anticoagulation center: Critical appraisal of real-world data. PLoS One. 2023; 18(2)DOI:10.1371/journal.pone.0279297. PMID:36827286. IF:2.900(Q1/3D).

Muñoz A.J., Souto J.C., Lecumberri R., Obispo B., Sanchez A., Aparicio J., Aguayo C., Gutierrez D., Palomo A.G., Fanjul V., del Rio-Bermudez C., Viñuela-Benéitez M.C., Hernández-Presa M.Á.. Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning. THROMBOSIS RESEARCH. 2023; 228DOI:10.1016/j.thromres.2023.06.015. PMID:37348318. IF:3.700(Q1/3D).

Megias-Vericat, JE, Boix, SB, Moreno, RB, Mingot-Castellano, ME, Lopez, MR, Hirnyk, MC, Arranz, JM, Villas, JMC, Guaita, SH, Meda, MM, Jaime, FL, Albo-Lopez, C, Palomero-Massanet, A, Seto, NV, Lecinena, IL, Haro, ARC, Andres, JLP. Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products. THROMBOSIS RESEARCH. 2022; 216DOI:10.1016/j.thromres.2022.06.001. PMID:35696967. IF:7.500(Q1/2D).

Gonzalez-Porras, JR, Mateo, J, Gonzalez-Calle, V, Marco, P, Garcia-Gutierrez, V, Reverter, JC, Lecumberri, R. Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH-SETH. Clinical & Translational Oncology. 2022; 24(5)DOI:10.1007/s12094-021-02735-1. PMID:34850351. IF:3.400(Q3/6D).

Gil, AD, Suarez, GMG, Puig, CM, Ganoza, AH. Superwarfarin poisoning: challenges still remain. Bmj Case Reports. 2022; 15(5)DOI:10.1136/bcr-2021-248385. PMID:35584857. IF:(Q/D).

Jimenez-Yuste, V, Alvarez-Roman, MT, Bravo, AP, Galmes, BJ, Hernandez, MDN, Hidalgo, OB, Alonso, CM, Gonzalez, NFP, Coll, J, Nunez, R, Carrasco, M, Candel, FG, Gonzalez-Porras, JR, Garcia, CH, Castro, MJV, Mir, R. Clinical Efficacy and Safety of Fanhdi(R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. 2022; 28DOI:10.1177/10760296221074348. PMID:35108125. IF:2.900(Q3/6D).

Soto, I, Mateo, J, Garcia-Diego, DA, Gil, B, Ruiz-Beato, E, Ivanova, Y, Lorenzo, TM, Maravilla-Herrera, P, Hidalgo-Vega, A, Merino, M. The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis. BMC HEALTH SERVICES RESEARCH. 2022; 22(1)DOI:10.1186/s12913-021-07447-4. PMID:35081958. IF:2.800(Q3/6D).

Paramo, JA, Lozano, ML, Gonzaalez-Porras, JR, Mateo, J. Current status of diagnosis and treatment of heparin-induced thrombocytopenia (HIT). MEDICINA CLINICA. 2022; 158(2)DOI:10.1016/j.medcli.2021.05.020. PMID:34311973. IF:3.900(Q2/4D).

Corrochano M., Acosta-Isaac R., Plaza M., Muñoz R., Mojal S., Moret C., Souto J.C.. Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants. PLoS One. 2022; 17(12)DOI:10.1371/journal.pone.0278693. PMID:36490245. IF:3.700(Q2/4D).

Perez-Rodriguez, A, Batlle, J, Pinto, JC, Corrales, I, Borras, N, Garcia-Martinez, I, Cid, AR, Bonanad, S, Parra, R, Mingot-Castellano, ME, Navarro, N, Altisent, C, Perez-Montes, R, Moreto, A, Herrero, S, Soto, I, Mosteirin, NF, Jimenez-Yuste, V, Jacob, AD, Fontanes, E, Mateo, J, Quismondo, NC, Batlle, F, Vidal, F, Lopez-Fernandez, MF. Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES project. HAEMOPHILIA. 2021; 27(6)DOI:10.1111/hae.14405. PMID:34494337. IF:4.268(Q2/5D).

Mingot-Castellano, ME, Pardos-Gea, J, Haya, S, Bastida-Bermejo, JM, Tassies, D, Marco-Rico, A, Nunez, R, Garcia-Candel, F, De Mora, MCFS, Soto, I, Alvarez-Roman, MT, Asenjo, S, Carrasco, M, Lluch-Garcia, R, Martin-Antoran, JM, Rodriguez-Alen, A, Rosello, E, Torres-Minana, L, Marcellini-Antonio, S, Moreto-Quinana, A, Rodriguez-Garcia, JA, Aguinaco-Culebras, R, Alonso-Escobar, N, Cervero-Santiago, C, Fernandez-Mosteirin, N, Martinez-Badas, MP, Perez-Sanchez, M, Perez-Montes, R, Rodriguez-Gonzalez, R, Uribe-Barrientos, M, Caparros-Miranda, IS, Iglesias-Fernandez, M, Baena, A, Rodriguez-Lopez, M, Sebrango-Sandia, A, Vazquez-Fernandez, I, Marco, P. Management of acquired hemophilia A: results from the Spanish registry. Blood Advances. 2021; 5(19)DOI:10.1182/bloodadvances.2021004626. PMID:34521101. IF:7.642(Q1/3D).

Roman, MTA, Benitez, O, Canaro, MI, Fernandez, MFL, Jaime, FLJ, Arranz, JM, Nunez, R, Lopez, MR, Aisa, CS, Jimenez-Yuste, V. Expert opinion paper on the treatment of hemophilia B with albutrepenonacog alfa. EXPERT OPINION ON BIOLOGICAL THERAPY. 2021; 21(9)DOI:10.1080/14712598.2021.1932811. PMID:34225551. IF:5.589(Q1/3D).

Garcia-Ribera, C, Carrasco, M, Ruiz-Ripoll, A. Covid-19, hypercoagulability and risk of mortality in schizophrenia. ACTAS ESPANOLAS DE PSIQUIATRIA. 2021; 49(4)DOI:. PMID:34195973. IF:1.667(Q4/9D).

Marzo, C, Solanich, T, Tassies, D, Pina, E, Rebollo, MA, Gallardo, E, Serradell, S, Merino, M, Carrasco, M, Tugues, A. Consensus on the Management of the Clinical Challenges of Venous Thromboembolism in Special Situations. THROMBOSIS AND HAEMOSTASIS. 2025; 125(10)DOI:10.1055/a-2595-1811. PMID:40359988. IF:4.300(Q1/2D).

Berrueco, R, Soto, I, Bastida, JM, Villas, JMC, de Cos, C, Haya, S, García, FS, Arranz, JM. Patient-Centred Management of Well-Controlled Haemophilia: Obtaining Opinions and Definitions Through a Delphi Consensus. Journal of Clinical Medicine. 2025; 14(10)DOI:10.3390/jcm14103300. PMID:40429300. IF:2.900(Q1/2D).

Hernández-Rodríguez, J, Martínez-Valle, F, Acebes, X, Alerany, C, Antón, J, Calvo, G, Corral, M, Cruz, J, Mangues-Bafalluy, MA, Mateo, J, Rivera, J, Salazar, A, Francisco, R, Mallol, C, Reig-Viader, R, Tigri-Santiña, A, Ricart, A, Palau, F. Identification of strengths and weaknesses of the healthcare system for persons living with rare diseases in Catalonia (Spain), and recommendations to improve its comprehensive attention: the "acERca las enfermedades raras" project. Orphanet Journal of Rare Diseases. 2025; 20(1)DOI:10.1186/s13023-024-03518-x. PMID:39875900. IF:3.500(Q2/4D).

Hidalgo, OB, Alonso, CM, Jaime, FJL, Carrasco, M, Hernández, MDN, Afonso, N, Lei, A, Whyms, D, Hanna, K, Aragonés, ME, Torres, M, Oliveras, J. Safety and Efficacy of the Use of pdVWF/FVIII-C in Patients with von Willebrand Disease: A Prospective, Observational, Post-Authorization Study. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. 2025; 31DOI:10.1177/10760296251327593. PMID:40079811. IF:2.000(Q3/6D).

Vilalta, N, Oñate, G, Triquell, M, Carrasco, M, Mateo, J. Acquired FXIII Deficiency Secondary to a Myelodysplastic Syndrome. HAEMOPHILIA. 2025; 31DOI:. PMID:. IF:3.000(Q2/4D).

Vilalta, N, Triquell, M, Llobet, D, Simón, M, Cerdà, N, Carrasco, M, Mateo, J. Prospective View of Emicizumab Treatment According Thrombin Generation Time. HAEMOPHILIA. 2025; 31DOI:. PMID:. IF:3.000(Q2/4D).

Walter, A, Winsauer, H, Crespo, E, Walter, D, Winsauer, C, Schwärzler, A, Mojal, S, Arcos, I, Puigdollers, A. Adult maxillary expansion: CBCT evaluation of skeletal changes and determining an efficiency factor between force-controlled polycyclic slow activation and continuous rapid activation for mini-screw-assisted palatal expansion - MASPE vs. MARPE. Head & Face Medicine. 2024; 20(1)DOI:10.1186/s13005-024-00474-6. PMID:39617918. IF:2.600(Q2/3D).